Free Websites at Nation2.com






Total Visits: 304
Anthony Harrelson North Carolina

Anthony Harrelson of North Carolina - Groundbreaking Biopharmaceutical Research

Anthony Harrelson of North Carolina founded White Oak Industries, a biopharmaceutical company. Over the past several years, White Oak Industries has been focused on creating new immunotherapeutic treatments for viral infections. Dr. Harrelson hopes that his research and development team can produce a comprehensive treatment for severe viral infections, including those caused by HIV and Ebola. Dr. Harrelson and his team hope they can create drugs that train the body to attack certain antigens that they choose. One way to do this, the research team found, is by manipulating the body’s dendritic cells. These cells are the on/off switch of the body’s entire immune system. They tell where the antibodies and T cells should attack foreign particles. Dr. Harrelson’s treatments are aimed at dendritic cells, attempting to reprogram them to attack viruses and infected cells.

Dr. Anthony Harrelson of North Carolina says that there is still a long way to go before his team can produce a comprehensive HIV vaccine, but the potential for the end of HIV and AIDS is real. Harrelson says that there are many steps that have to be completed along the way. The first step is expanded testing of his treatments. Immunotherapy is still considered a theoretical concept, and will continue to be until definitive tests can be performed. The first wave of testing will be on animals, to see if immunotherapy can destroy viral infections throughout an organism’s entire body. Anthony Harrelson of North Carolina says that he hopes to expand his testing to rats and other rodents soon to show the potential of his company’s ongoing research.

Anthony Harrelson of North Carolina - Help from Matt Kauffman

Anthony Harrelson of North Carolina founded the biopharmaceutical company White Oak Industries. He now heads the company, and he says that it is closer than ever to realizing its goal of providing groundbreaking immunotherapeutic treatments for infectious viral diseases like Ebola and HIV. Dr. Harrelson says his treatments train the body’s immune system to target and eliminate certain antigens by manipulating the body’s dendritic cells. Dendritic cells act as the generals of the body’s army of defense cells. They direct where the immune system should send antibodies and T cells. Harrelson’s treatment reprograms some of these dendritic cells to send the body’s defense cells to attack certain viral cells anywhere in the body. This ensures that the virus is completely eliminated in all tissues of the body and disallows the virus from replicating itself.

Anthony Harrelson of North Carolina says that there are many steps to come before his dream of commercialized viral vaccines for all is realized. The first step is expanded testing. This immunotherapy is still a highly theoretical concept from the perspective of hard science. Harrelson hopes to expand his testing to rodents in order to show without doubt that the immunotherapy can destroy viruses throughout an organism’s entire body. After animal testing, Dr. Harrelson wants to move on to human testing, starting with patients who would otherwise not be able to get treatment for their viral diseases. Next are clinical trials, which further test the effects of the treatment on human patients. This testing stage is the most important because it determines if the treatment is a viable option for sufferers of viral conditions around the world.